Satellos Bioscience Inc（MSLE）の株価予測

$9.080

-0.252 (-2.78%)終値時点

価格予想

1-Day Price Prediction

-0.17%

1-Week Prediction

-1.42%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

アプリで開くと、より長期の予想を確認できます。

Loading chart…

類似チャート分析による MSLE の予測・予想

Alphio's MSLE stock price prediction model matches the current Satellos Bioscience Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.06 (-0.17%). The 1-week path is $8.95 (-1.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Satellos Bioscience Inc 株は買うべき？

Currently, Satellos Bioscience Inc (MSLE) is trading at $8.66, down 26.70% year-to-date, which indicates a significant decline. Despite receiving FDA Fast Track Designation for its drug SAT-3247, the company has reported consistent net losses, with the latest quarterly net income at -11,718,000 USD. Analysts have set a price target range from $18 to $23, suggesting a potential upside of 107% to 165%. However, the RSI is at 22.546, indicating the stock is oversold, which may present a buying opportunity, but the persistent losses and high risk associated with clinical trials remain a concern.